Potassium Trajectories prior to Dialysis and Mortality following Dialysis Initiation in Patients with Advanced CKD.


Journal

Nephron
ISSN: 2235-3186
Titre abrégé: Nephron
Pays: Switzerland
ID NLM: 0331777

Informations de publication

Date de publication:
2021
Historique:
received: 25 09 2020
accepted: 04 01 2021
pubmed: 23 3 2021
medline: 15 12 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

Patients with advanced non-dialysis-dependent CKD (NDD-CKD) have a reduced ability for maintaining plasma potassium (K) in normal range. Deviation from normal plasma K ranges is associated with increased mortality; however, the average trajectory of plasma K over time in patients with advanced NDD-CKD and the outcomes associated with plasma K trajectory are unknown. We identified 34,167 US veterans with advanced NDD-CKD transitioning to dialysis between October 2007 and March 2015 with at least 1 K measurement each year over a 3-year period prior to dialysis transition (3-year prelude). The K trajectory defined as the change in K (slope) per year over the entire 3-year prelude was estimated using linear mixed-effects models. The association between unadjusted (crude) K slope (categorized as stable [-0.09 to 0.09 mEq/L/year], decreasing [≤-0.10 mEq/L/year], and increasing [≥0.10 mEq/L/year]) and time to all-cause and cardiovascular mortality during the 6 months following dialysis initiation was assessed using multivariable-adjusted survival models. The crude and multivariable-adjusted K slopes (mean, 95% CI) over the 3-year prelude were 0.008 (0.0059, 0.0110) and -0.15 mEq/L/year (-0.19, -0.11), respectively. Decreasing K slope was associated with higher multivariable-adjusted risk of all-cause mortality (adjusted hazard ratio [95% CI] vs. stable K slope: 1.08 [1.00-1.17]). No association was observed between K slope and cardiovascular mortality. The average intraindividual plasma K trajectory is remarkably stable in patients with advanced NDD-CKD. A decreasing K slope is associated with higher all-cause mortality risk.

Identifiants

pubmed: 33752200
pii: 000514294
doi: 10.1159/000514294
pmc: PMC8102350
mid: NIHMS1668086
doi:

Substances chimiques

Potassium RWP5GA015D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-274

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK102163
Pays : United States

Informations de copyright

© 2021 S. Karger AG, Basel.

Références

Nephrol Dial Transplant. 2019 Nov 1;34(11):1894-1901
pubmed: 29986054
JAMA. 2012 Jan 11;307(2):157-64
pubmed: 22235086
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48
pubmed: 20150448
Int Urol Nephrol. 2016 May;48(5):725-9
pubmed: 26886110
Mayo Clin Proc. 2016 Oct;91(10):1403-1412
pubmed: 27499535
Am J Clin Nutr. 2013 Jun;97(6):1163-77
pubmed: 23636234
Am J Nephrol. 2017;46(3):213-221
pubmed: 28866674
J Am Heart Assoc. 2019 Mar 19;8(6):e011869
pubmed: 30885048
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8
pubmed: 30798791
Nephrol Dial Transplant. 2019 Dec 1;34(Suppl 3):iii19-iii25
pubmed: 31800082
Circ Arrhythm Electrophysiol. 2017 Mar;10(3):
pubmed: 28314851
Am J Nephrol. 2017;46(5):397-407
pubmed: 29130991
Eur Heart J. 2018 May 1;39(17):1535-1542
pubmed: 29554312
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):245-252
pubmed: 28143865
Nicotine Tob Res. 2011 Dec;13(12):1233-9
pubmed: 21911825
Adv Chronic Kidney Dis. 2017 Sep;24(5):315-318
pubmed: 29031358
Nephrol Dial Transplant. 2018 Sep 1;33(9):1610-1620
pubmed: 29177463
J Ren Nutr. 2020 Jul;30(4):276-285
pubmed: 31734057
Clin J Am Soc Nephrol. 2016 May 6;11(5):821-31
pubmed: 27103623
J Clin Invest. 1971 May;50(5):1061-8
pubmed: 5552407
Am J Kidney Dis. 2004 May;43(5 Suppl 1):S1-290
pubmed: 15114537
Stroke. 2017 Nov;48(11):2973-2978
pubmed: 28974633
Kidney Int. 2020 Jan;97(1):42-61
pubmed: 31706619
Kidney Int. 1981 Oct;20(4):482-90
pubmed: 7311308
Circulation. 2015 Oct 20;132(16):1538-48
pubmed: 26384521
Am J Med. 1984 Nov 5;77(5A):18-27
pubmed: 6496556
J Clin Hypertens (Greenwich). 2002 May-Jun;4(3):198-206
pubmed: 12045369
J Acad Nutr Diet. 2014 Jul;114(7):1077-87
pubmed: 24582998
Clin J Am Soc Nephrol. 2010 May;5(5):762-9
pubmed: 20203167
Rev Cardiovasc Med. 2014;15(1):11-23
pubmed: 24762462
J Am Heart Assoc. 2018 May 22;7(11):
pubmed: 29789332
Am J Nephrol. 2015;41(6):456-63
pubmed: 26228532
Am J Kidney Dis. 2017 Dec;70(6):844-858
pubmed: 29029808
Nutrients. 2018 Feb 25;10(3):
pubmed: 29495340
Arch Intern Med. 2009 Jun 22;169(12):1156-62
pubmed: 19546417
Am J Kidney Dis. 2017 Jul;70(1):21-29
pubmed: 28111027
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):90-100
pubmed: 26500246

Auteurs

Ankur A Dashputre (AA)

Institute for Health Outcomes and Policy, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Keiichi Sumida (K)

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Praveen K Potukuchi (PK)

Institute for Health Outcomes and Policy, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Suryatapa Kar (S)

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Yoshitsugu Obi (Y)

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Fridtjof Thomas (F)

Division of Biostatistics, Department of Preventive Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Miklos Z Molnar (MZ)

Division of Nephrology and Hypertension, Department of Medicine, University of Utah, Salt Lake City, Utah, USA.

Elani Streja (E)

Division of Nephrology and Hypertension, Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California-Irvine, Orange, California, USA.

Kamyar Kalantar-Zadeh (K)

Division of Nephrology and Hypertension, Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California-Irvine, Orange, California, USA.

Csaba P Kovesdy (CP)

Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA, ckovesdy@uthsc.edu.
Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee, USA, ckovesdy@uthsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH